Skip to Content Skip to Navigation

About us Practical matters How to find us drs. J.M. van Rooijen

drs. J.M. van Rooijen

No picture available

Faculty of Medical Sciences

Telephone:

E-mail:

j.m.van.rooijen umcg.nl

Research Portal

Publications

Managed Clinical Network for esophageal cancer enables reduction of variation between hospitals trends in treatment strategies, lead time, and 2-year survival

van Hoeve, J. C., Verhoeven, R. H. A., Nagengast, W. B., Oppedijk, V., Lynch, M. G., van Rooijen, J. M., Veldhuis, P., Siesling, S. & Kouwenhoven, E. A., Jan-2023, In: European Journal of Surgical Oncology. 49, 1, p. 106-112 7 p.

Research output: Contribution to journal › Article › Academic › peer-review

Genomic landscape and actionable targets as identified by whole genome sequencing and RNA sequencing in patients with advanced renal cell carcinoma

Joode, K. D., van de Geer, W. S., van Leenders, G. J. L. H., Hamberg, P., Westgeest, H. M., Beeker, A., Oosting, S. F., van Rooijen, J. M., Beerepoot, L. V., Labots, M., Mathijssen, R. H., Lolkema, M. P., Cuppen, E., Sleijfer, S., van de Werken, H. J. G. & Van der Veldt, A. A. M., Dec-2021, In: Annals of Oncology. 32, p. S1386-S1386 1 p.

Research output: Contribution to journal › Meeting Abstract › Academic

Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study

PLCRC-MEDOCC group, Schraa, S. J., van Rooijen, K. L., van der Kruijssen, D. E. W., Rubio Alarcón, C., Phallen, J., Sausen, M., Simmons, J., Coupé, V. M. H., van Grevenstein, W. M. U., Elias, S., Verkooijen, H. M., Laclé, M. M., Bosch, L. J. W., van den Broek, D., Meijer, G. A., Velculescu, V. E., Fijneman, R. J. A., Vink, G. R. & Koopman, M., 20-Aug-2020, In: BMC Cancer. 20, 1, 10 p., 790.

Research output: Contribution to journal › Article › Academic › peer-review

High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

Qiu, S.-Q., van Rooijen, J., Nienhuis, H. H., van der Vegt, B., Timmer-Bosscha, H., van Leeuwen-Stok, E., Walenkamp, A. M. E., van Deurzen, C. H. M., de Bock, G. H., de Vries, E. G. E. & Schroder, C. P., 18-Mar-2020, In: Breast cancer research. 22, 1, 10 p., 30.

Research output: Contribution to journal › Article › Academic › peer-review

Optimizing systemic therapy in metastatic breast cancer: implementation in daily practice and exploration of new drug targets

van Rooijen, J., 2020, [Groningen]: Rijksuniversiteit Groningen. 144 p.

Research output: Thesis › Thesis fully internal (DIV)

Androgen receptor expression inversely correlates with immune cell infiltration in human epidermal growth factor receptor 2-positive breast cancer

van Rooijen, J. M., Qiu, S.-Q., Timmer-Bosscha, H., van der Vegt, B., Boers, J. E., Schröder, C. P. & de Vries, E. G. E., Nov-2018, In: European Journal of Cancer. 103, p. 52-60 9 p.

Research output: Contribution to journal › Article › Academic › peer-review

Use of trastuzumab for HER2-positive metastatic breast cancer in daily practice: A population-based study focusing on the elderly

van Rooijen, J. M., de Munck, L., Teeuwen, G. M., de Graaf, J. C., Jansman, F. G., Boers, J. E. & Siesling, S., Feb-2016, In: Anti-Cancer Drugs. 27, 2, p. 127-32 6 p.

Research output: Contribution to journal › Article › Academic › peer-review

A 21-Year-Old Patient With a HER2-Positive Colorectal Cancer

Bensch, F., van Rooijen, J. M., Schröder, C. P. & Reyners, A. K. L., Jan-2015, In: Gastroenterology. 148, 1, p. 20-21 2 p.

Research output: Contribution to journal › Editorial › Academic › peer-review

Immunotherapeutic options on the horizon in breast cancer treatment

van Rooijen, J. M., Stutvoet, T. S., Schröder, C. P. & de Vries, E. G. E., Dec-2015, In: Pharmacology & Therapeutics. 156, p. 90-101 12 p.

Research output: Contribution to journal › Review article › peer-review

All (9) publications

View full research profile

Follow the UGfacebook linkedin rss instagram youtube